Additionally, the results suggest that routine examinations conducted to determine serum IgG-Fn status prior to treatment may contribute to development of more effective treatment strategies, particularly for patients with advanced ESCC. The gene discussed is FN1; the disease is esophageal squamous cell carcinoma.